Tag: <span>COVID-19</span>

Home / COVID-19
Study shows inexpensive, readily available chemical may limit impact of COVID-19
Post

Study shows inexpensive, readily available chemical may limit impact of COVID-19

by University of California, Los Angeles Transmission electron micrograph of SARS-CoV-2 virus particles (colored yellow) within the endosomes of a heavily infected nasal olfactory epithelial cell. Credit: NIAID Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new...

Myocarditis seven times more likely with COVID-19 than vaccines
Post

Myocarditis seven times more likely with COVID-19 than vaccines

by Tracy Cox, Pennsylvania State University Credit: Pixabay/CC0 Public Domain The risk of developing myocarditis—or inflammation of the heart muscle—is seven times higher with a COVID-19 infection than with the COVID-19 vaccine, according to a recent study by Penn State College of Medicine scientists, now published in Frontiers in Cardiovascular Medicine. Patients with myocarditis can experience...

Four easy ways to reduce your risk of severe COVID-19
Post

Four easy ways to reduce your risk of severe COVID-19

by Kelsey Simpkins,  University of Colorado at Boulder Spices and herbs, whether fresh or dried, are important foods for the microbes in out gut that help keep our bodies in balance. Credit: Unsplash/CC0 Public Domain Lifestyle choices—such as eating healthy, staying active as well as resting after exercise, and managing stress—may help prevent people from developing...

Post

COVID-19 associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72%

CASE WESTERN RESERVE UNIVERSITY CLEVELAND–Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger. In a study published today in the journal JAMA Network Open, researchers at the Case...

COVID-19: One in three infected, unvaccinated people no longer have detectable antibodies one year after infection
Post

COVID-19: One in three infected, unvaccinated people no longer have detectable antibodies one year after infection

by Barcelona Institute for Global Health Sign in a Catalan vaccine center. Credit: Hospital Clinic A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected, and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting. The study has been published in BMC Medicine. Both infection and vaccination...

Risk factor for developing Alzheimer’s disease increases by 50-80% in older adults who have had COVID-19
Post

Risk factor for developing Alzheimer’s disease increases by 50-80% in older adults who have had COVID-19

by Case Western Reserve University Credit: Pixabay/CC0 Public Domain Older people who were infected with COVID-19 show a substantially higher risk—as much as 50% to 80% higher than a control group—of developing Alzheimer’s disease within a year, according to a study of more than 6 million patients 65 and older. In a study published today...

Scientists discover a novel mechanism leading to the inflammatory cytokine storm in COVID-19
Post

Scientists discover a novel mechanism leading to the inflammatory cytokine storm in COVID-19

by  Hospital for Special Surgery IFN-I response associated with pDCs precedes inflammatory response in macrophages from BAL fluids and lungs of patients with COVID-19. (A) Abundance of pDCs depending on disease state in BAL from DOI:10.1038/s41591-020-0901-9. (B) Abundance of IFN-I response for pDCs aggregated by disease state in BAL. (C) Inference of a pseudotime axis using...

India approves its first nasal vaccine for COVID-19
Post

India approves its first nasal vaccine for COVID-19

Credit: Unsplash/CC0 Public Domain India on Tuesday approved a locally developed, needle-free and nasally administered COVID-19 vaccine for emergency use, in a boost to the country’s homegrown pharmaceutical industry. The new inoculation was developed by Bharat Biotech, which had already developed an intravenous product greenlit by the World Health Organization last November.  India’s drug regulator...

New data shows COVID-19 vaccine does not raise stroke risk
Post

New data shows COVID-19 vaccine does not raise stroke risk

by  Cedars-Sinai Medical Center Credit: Cedars-Sinai Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk—but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the journal Neurology, will ease the...

Severe COVID-19 increases risk of life-threatening blood clots
Post

Severe COVID-19 increases risk of life-threatening blood clots

by Alex Gardner,  University of Pennsylvania Credit: Pixabay/CC0 Public Domain Individuals hospitalized with COVID-19 are more likely to develop venous thromboembolism—a potentially life-threatening condition—than those hospitalized with influenza, according to a new study from the Perelman School of Medicine. The study, published in the Journal of the American Medical Association, evaluates the absolute risk of hospitalized deep...